Viridian Therapeutics, Inc. VRDN Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s shares (diluted)?
- Viridian Therapeutics, Inc. (VRDN) reported shares (diluted) of 81.3M in Q1 2025.
- How has Viridian Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Viridian Therapeutics, Inc.'s shares (diluted) increased by 33.1% year-over-year, from 61.1M to 81.3M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s shares (diluted)?
- Over 2 years (2021 to 2023), Viridian Therapeutics, Inc.'s shares (diluted) has grown at a 115.2% compound annual growth rate (CAGR), from 37.5M to 173.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.